{
  "trial_id": "NCT00058812",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "T cell depleted BMT from mismatched family member or unrelated donor",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "matched sibling transplant or T replete transplant with high risk of developing EBV LPD",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "O2 saturation > 90% on room air",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "GVHD of Grade II or greater",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "severe renal disease (creatinine clearance less than half normal for age)",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "severe hepatic disease (bilirubin greater than twice normal, or SGOT greater than 3 x normal)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "severe intercurrent infection",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "life expectancy <6 weeks",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has CLL with large cell transformation, received multiple treatments including FCR and R-CVP, but did not have significant response. He was switched to Campath therapy and had resolution of lymphocytosis, but no reduction in bulky lymphadenopathy.",
  "_meta": {
    "topic_id": "8",
    "trial_id": "NCT00058812",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}